top of page
(OTC: KRTL)
Home
About
Team
Upstream Listing
News
Contact
Investors
Investor Relations
More
Use tab to navigate through the menu items.
KRTL News
All Posts
KRTL Biotech Inc. Strengthens Import Operations with Official Customs Broker Appointment, Paving the Way for Global API Expansion
Jul 30, 2025
KRTL Holding Group Inc. (OTC: KRTL) Bolsters Corporate Leverage with Trademark Recognition and Structural Integration
Jul 2, 2025
KRTL Biotech Inc. Advances API Supply Chain Strategy with $240,000 Initial Purchase Order
Jun 11, 2025
KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.
Jun 5, 2025
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
Jun 4, 2025
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Apr 8, 2025
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
Apr 1, 2025
KRTL Holding Group, Inc Approved to Dual List on Upstream
Mar 24, 2025
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
Mar 23, 2025
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
Mar 3, 2025
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
Feb 12, 2025
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
Feb 12, 2025
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
Feb 12, 2025
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
Feb 5, 2025
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
Jan 22, 2025
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
Jan 15, 2025
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
Jan 8, 2025
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
Jan 8, 2025
KRTL Holding Appoints David Orn to Board of Directors
Dec 19, 2024
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
Dec 5, 2024
bottom of page
